Yolanda Jimenez-Gomez
Overview
Explore the profile of Yolanda Jimenez-Gomez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
998
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alba-Molina D, Cano M, Blanco-Blanco M, Ortega-Llamas L, Jimenez-Gomez Y, Gonzalez-Lopez A, et al.
J Mater Chem B
. 2025 Jan;
13(9):3000-3010.
PMID: 39886840
Gold nanoparticles (AuNPs) play a key role in the field of nanomedicine due to their fascinating plasmonic properties as well as their great biocompatibility. An intriguing application is the use...
2.
Simoliunas E, Ruedas-Torres I, Jimenez-Gomez Y, Edin E, Aghajanzadeh-Kiyaseh M, Zamani-Roudbaraki M, et al.
NPJ Regen Med
. 2024 Mar;
9(1):11.
PMID: 38429307
Pathophysiologic inflammation, e.g., from HSV-1 viral infection, can cause tissue destruction resulting in ulceration, perforation, and ultimately blindness. We developed an injectable Cornea-in-a-Syringe (CIS) sealant-filler to treat damaged corneas. CIS...
3.
Martinez-Castillo R, Gonzalez-Gallardo C, Munoz-Avila J, Font P, Villalba-Gonzalez M, Stoikow I, et al.
Biomed Pharmacother
. 2023 Feb;
160:114368.
PMID: 36753959
Purpose: To evaluate long-term visual and anatomical outcomes in neovascular age-related macular degeneration (nAMD) patients treated with anti-vascular endothelial growth factor (VEGF) agents depending on the time delay from confirmed...
4.
Jimenez-Gomez Y, Alba-Molina D, Blanco-Blanco M, Perez-Fajardo L, Reyes-Ortega F, Ortega-Llamas L, et al.
Pharmaceutics
. 2022 Jul;
14(7).
PMID: 35890368
In recent years, the number of patients with ocular diseases is increasing as a consequence of population aging. Among them, one of the most common is the age-related macular degeneration...
5.
Ruiz-Limon P, Ladehesa-Pineda M, Lopez-Medina C, Lopez-Pedrera C, Abalos-Aguilera M, Barbarroja N, et al.
Diagnostics (Basel)
. 2021 Jul;
11(6).
PMID: 34199950
Endothelial dysfunction (ED) is well known as a process that can lead to atherosclerosis and is frequently presented in radiographic axial spondyloarthritis (r-axSpA) patients. Here, we investigated cellular and molecular...
6.
Arias de la Rosa I, Font P, Escudero-Contreras A, Lopez-Montilla M, Perez-Sanchez C, Abalos-Aguilera M, et al.
Ther Adv Chronic Dis
. 2021 Apr;
11:2040622320965067.
PMID: 33796240
Objective: To analyze the relationship between complement component 3 (C3) and the prevalence of cardiometabolic risk factors and disease activity in the rheumatic diseases having the highest rates of cardiovascular...
7.
Ladehesa-Pineda M, Arias de la Rosa I, Medina C, Castro-Villegas M, Del Carmen Abalos-Aguilera M, Ortega-Castro R, et al.
Ther Adv Musculoskelet Dis
. 2021 Jan;
12:1759720X20982837.
PMID: 33447266
Aims: To evaluate the association of estimated cardiovascular (CV) risk and subclinical atherosclerosis with radiographic structural damage in patients with axial spondyloarthritis (axSpA). Methods: Cross-sectional study including 114 patients axSpA...
8.
Arias de la Rosa I, Perez-Sanchez C, Ruiz-Limon P, Patino-Trives A, Torres-Granados C, Jimenez-Gomez Y, et al.
Haematologica
. 2020 Oct;
105(9):2250-2261.
PMID: 33054050
The aim of this study was to investigate the microRNA (miRNA) expression pattern in neutrophils from rheumatoid arthritis (RA) patients and its contribution to their pathogenic profile and to analyze...
9.
Ruiz-Limon P, Ladehesa-Pineda M, Castro-Villegas M, Del Carmen Abalos-Aguilera M, Lopez-Medina C, Lopez-Pedrera C, et al.
J Biomed Sci
. 2020 Apr;
27(1):54.
PMID: 32303225
Background: Radiographic axial spondyloarthritis (r-axSpA) is a chronic inflammatory form of arthritis in which tumor necrosis factor (TNF)-α, a potent inducer of inflammatory response and a key regulator of innate...
10.
Ruiz-Limon P, Ortega-Castro R, Barbarroja N, Perez-Sanchez C, Jamin C, Patino-Trives A, et al.
Front Immunol
. 2019 Jun;
10:1111.
PMID: 31169830
This study, developed within the Innovative Medicines Initiative Joint Undertaking project PRECISESADS framework, aimed at functionally characterize the monocyte subsets in RA patients, and analyze their involvement in the increased...